ChromaCode’s HDPCR™ SARS-CoV-2 assay has moved on to the Semi-Finals Spherical of the XPRIZE Speedy Covid Testing Competitors, aiming to extend Covid-19 testing capabilities 100-times previous our present customary.
R3 Vascular, a medical machine firm which developed a expertise platform for producing bioresorbable vascular scaffolds (BVS) expertise to deal with peripheral artery illness, has closed a $17.8 million Sequence A spherical. An unnamed company investor and 415 CAPITAL led the spherical. HBM-MedFocus LLC and Wexford Capital additionally participated. Click here to read more.
Current Health has partnered with the Biomedical Superior Analysis and Improvement Authority (BARDA) – a part of the Assistant Secretary for Preparedness and Response throughout the U.S. Division of Well being and Human Providers – to help healthcare suppliers in monitoring COVID-19 sufferers, detecting deterioration of their well being and predicting illness severity. Present Well being’s steady distant monitoring platform shall be used to handle and deal with COVID-positive sufferers and develop a digital biomarker-based algorithm that can be capable of predict want for hospitalization and ICU-level care. Click here to read more.
Datavant, a well being IT firm, obtained $40 million in Sequence B funding. Transformation Capital led the spherical with participation by new traders Johnson & Johnson Innovation – JJDC, Inc. and Cigna Ventures. Present shareholders additionally took half, together with Roivant Sciences and Flex Capital. Datavant’s expertise allows a match between a consenting affected person’s examine knowledge and their actual world knowledge. Click here to read more.
Are you a well being IT, diagnostics or life science startup targeted on precision drugs or enabling precision drugs or personalised drugs? Submit an utility to pitch at INVEST Precision Medicine (virtual) December 9-11. Click here to apply.
Image: akindo, Getty Photographs